Related Experiment Video
Updated: Dec 19, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study
Yumie Kobayashi1, Satoko Ohfuji2, Kyoko Kondo3
1Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
A lower ratio of n-6/n-3 polyunsaturated fatty acids in the diet may decrease ulcerative colitis (UC) risk. However, high intake of specific omega-3 fatty acids like DHA and EPA may increase UC risk.
Area of Science:
- Gastroenterology
- Nutritional Science
- Epidemiology
Background:
- Dietary fatty acids are implicated in chronic intestinal inflammation, including ulcerative colitis (UC).
- Previous research on fatty acids and UC risk is primarily from Western countries.
- Japanese dietary habits differ, featuring lower meat and higher fish consumption.
Purpose of the Study:
- To investigate the association between dietary fatty acid intake and the risk of developing ulcerative colitis in Japan.
- To explore how specific fatty acid ratios and individual fatty acids relate to UC risk in a Japanese population.
Main Methods:
- A multicenter case-control study involving 83 newly diagnosed UC patients and 128 matched controls.
- Dietary fatty acid intake was assessed for the preceding 1 month and 1 year using a Japanese diet history questionnaire.
- Data collection occurred between 2008 and 2014, with most UC patients experiencing initial symptoms within 11 months prior.
Main Results:
- A ratio of n-6/n-3 polyunsaturated fatty acids (PUFAs) ≥5.2 was associated with a significantly decreased risk for UC (OR=0.26).
- Conversely, high consumption of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA) correlated with an increased UC risk.
- Specific odds ratios for increased risk were: DHA (7.22), EPA (6.91), and DPA (4.83).
Conclusions:
- The ratio of n-6/n-3 PUFAs intake appears to be a significant factor in reducing UC development risk.
- High dietary intake of DHA, EPA, and DPA may be associated with an elevated risk of developing ulcerative colitis.
- Findings highlight the complex role of specific dietary fatty acids in UC pathogenesis within the Japanese population.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.